دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening
Michael S. Leapman, MD; Rong Wang, PhD; Henry Park, MD, MPH; et al.
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer
Christopher J. D. Wallis, MD, PhD; Zhiguo Zhao, MS; Li-Ching Huang, PhD; et al.
Outcomes of Screening for Prostate Cancer Among Men Who Use Statins
Arla Vettenranta, MD; Teemu J. Murtola, MD, PhD; Jani Raitanen, MSc; et al.
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
Mariana Chavez-MacGregor, MD, MSC; Xiudong Lei, PhD; Hui Zhao, PhD; et al.
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic LeukemiaA Report From the Children’s Oncology Group AAML1331 Trial
Matthew A. Kutny, MD; Todd A. Alonzo, PhD; Oussama Abla, MD; et al.
Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma
Winta T. Mehtsun, MD, MPH; Nadine J. McCleary, MD, MPH; Ugwuji N. Maduekwe, MD; et al.
Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast CancerA Randomized Phase 3 Clinical Trial
Yong Bae Kim, MD, PhD; Hwa Kyung Byun, MD, PhD; Dae Yong Kim, MD, PhD; et al.
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Maximilian J. Mair, MD; Julia M. Berger; Anna S. Berghoff, MD, PhD; et al.
Time-Dependent COVID-19 Mortality in Patients With CancerAn Updated Analysis of the OnCovid Registry
OnCovid Study Group
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerLong-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas, MD, DPhil; Anke Schlenska-Lange, MD; Bülent Polat, MD; et al.
Assessment of Out-of-Pocket Costs With Rebate Pass-through for Brand-name Cancer Drugs Under Medicare Part D
Thomas J. Hwang, AB; Xuanzi Qin, PhD, MSPH; Nancy L. Keating, MD, MPH; et al.
Progress Against Cancer Mortality 50 Years After Passage of the National Cancer Act
Tyler B. Kratzer, MPH; Rebecca L. Siegel, MPH; Kimberly D. Miller, MPH; et al.
Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City
Stephanie Cham, MD; Alicia Li, BA; J. Alejandro Rauh-Hain, MD, MPH; et al.
Evaluation of Telemedicine Use Among US Patients With Newly Diagnosed Cancer by Socioeconomic Status
Aaron J. Katz, PharmD, PhD; Kevin Haynes, PharmD, MSCE; Simo Du, MBBS, MHS; et al.
Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines
Alexandra L. Potter; Chi-Fu Jeffrey Yang, MD; Kirsten M. Woolpert, MPH; et al.
SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments
Kalpana Parvathaneni, PhD; Kyabeth Torres-Rodriguez; Wenzhao Meng, PhD; et al.
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint InhibitorsA Systematic Review
Emily R. Nadelmann, BA, MD; Jennifer E. Yeh, MD, PhD; Steven T. Chen, MD, MPH, MS-HPEd
Understanding the Implications of Medicaid Expansion for Cancer Care in the USA Review
Theresa Ermer, MD; Samantha L. Walters, MHS; Maureen E. Canavan, PhD, MPH; et al.
Immunotherapy for Patients With Small-Cell Lung Cancer—2 Gains, 2 Losses
Harpreet Singh, MD; Julia A. Beaver; Richard Pazdur, MD
Mammographic Density Laws and Inclusion—Time for Change
Katherine Y. Tossas, PhD; Robert A. Winn, MD; Victoria L. Seewaldt, MD
Prostate-Specific Antigen Testing for Prostate Cancer Screening—Is the Message Getting Through?
Freddie C. Hamdy, MD
Decisional Regret Among Men With Prostate CancerWhat Is Involved?
Randy A. Jones, PhD, RN
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non–Small Cell Lung Cancer
Lu Tian, ScD; Bo Huang, PhD; Lee-Jen Wei, PhD
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non–Small Cell Lung Cancer
Akhil Kapoor, MBBS, MD, DM; Kumar Prabhash, DM
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non–Small Cell Lung Cancer—Reply
Salma K. Jabbour, MD; Steven M. Keller, MD; Martin Reck, MD, PhD
Association of Adiposity With Mortality Among Black Patients With Breast Cancer
Zhiyong Guo, PhD; Jiannan Liu, MD, PhD; Chenping Zhang, MD, PhD
Association of Adiposity With Mortality Among Black Patients With Breast Cancer—Reply
Elisa V. Bandera, MD, PhD; Bo Qin, PhD; Chi-Chen Hong, PhD
Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer
Steven Sorscher, MD
Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer—Reply
Thomas W. P. Friedl, PhD; Wolfgang Janni, MD; Brigitte Rack, MD
